Home
All updates
EDGE Insights
Industries
Company Search
My Watchlists (Beta)

All Updates

Filter

Regulation/policy

PoLoPo submits application for USDA approval of its SuperAA platform

Plant-based Dairy & Egg

May 22, 2024

This week:

Funding

Matr Foods raises EUR 20 million in debt funding to build mycelium meat factory

Plant-based Meat

Today

Last week:

M&A

Platform Science to acquire Trimble's global transportation telematics business units

Truck Industry Tech

Yesterday

Funding

Whatfix raises USD 100 million in Series E funding to expand business

EdTech: Corporate Learning

Yesterday

Product updates

Sky Mavis launches cross-game onboarding solution

Web3 Ecosystem

Sep 14, 2024

Funding

Bicara Therapeutics raises USD 315 million in IPO; plans to develop lead candidate ficerafusp alfa

Precision Medicine

Sep 13, 2024

Partnerships

Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment

Precision Medicine

Sep 13, 2024

Partnerships

Moffitt Cancer Center partners with AstraZeneca to advance oncology cell therapies

Cell & Gene Therapy

Sep 13, 2024

Product updates

Quandela launches European quantum computer in North America

Quantum Computing

Sep 13, 2024

Partnerships

IonQ achieves high qubit gate fidelity on barium development platform

Quantum Computing

Sep 13, 2024

Partnerships

Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment

Clinical Trial Technology

Sep 13, 2024

Plant-based Dairy & Egg

View industry hub

May 22, 2024

PoLoPo submits application for USDA approval of its SuperAA platform

Regulation/policy

Israeli company PoLoPo, specializing in molecular farming, has applied for a Regulatory Status Review (RSR) from the US Department of Agriculture's Animal and Plant Health Inspection Service for its SuperAA platform.
The SuperAA platform is a proprietary system that uses metabolic engineering techniques to turn potatoes into miniature biofactories to create alternative proteins. The proteins are then extracted and dry-processed into a powder compatible with existing food production lines. The final protein powder is classified as non-GMO despite the initial genetic engineering.
Analyst QuickTake: The company unveiled the SuperAA platform in March 2024 to develop ovalbumin and patanin for various food tech applications, including plant-based eggs and dairy alternatives. This unveiling followed the company’s USD 1.75 million pre-seed funding round held in March 2023.

Contact us

Gain access to all industry hubs, market maps, research tools, and more

Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.